Compounds > 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Page last updated: 2024-10-21

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Insulin Resistance

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine has been researched along with Insulin Resistance in 1 studies

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine : A tetrahydropyridine that is 1,2,3,6-tetrahydropyridine substituted by a methyl group at position 1 and a phenyl group at position 4.

Insulin Resistance: Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bousquet, M1
St-Amour, I1
Vandal, M1
Julien, P1
Cicchetti, F1
Calon, F1

Other Studies

1 other study available for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Insulin Resistance

ArticleYear
High-fat diet exacerbates MPTP-induced dopaminergic degeneration in mice.
    Neurobiology of disease, 2012, Volume: 45, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Chemokine CCL2; Chemokine CCL3; Corpus Striat

2012